RonanRX (YC S26) Builds Vertically Integrated Pharmacy for Personalized GLP-1 Treatments
RonanRX, a Y Combinator S26 startup co-founded by Lloyd, is building a fully integrated pharmaceutical company covering telehealth, compounding, manufacturing, and drug delivery. The company focuses on GLP-1 medications and peptides, aiming to replace fragmented, manual pharmacy workflows with a software-driven, data-connected system. Patients who enroll share medical records, lab results, and wearable data, allowing doctors to continuously adjust personalized dosages based on real-time treatment responses. By owning the entire supply chain from molecule to doorstep, RonanRX claims its drugs are 3 to 10 times more affordable than traditional channels. The founder's own transformative experience with tirzepatide, including potential delay of a lifelong heart surgery, directly inspired the venture's focus on personalized GLP-1 therapy.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in